403 related articles for article (PubMed ID: 26757748)
1. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
[TBL] [Abstract][Full Text] [Related]
2. Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue.
Haacke EA; van der Vegt B; Meiners PM; Vissink A; Spijkervet FK; Bootsma H; Kroese FG
Clin Exp Rheumatol; 2017; 35(2):317-320. PubMed ID: 27908305
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.
Pijpe J; Meijer JM; Bootsma H; van der Wal JE; Spijkervet FK; Kallenberg CG; Vissink A; Ihrler S
Arthritis Rheum; 2009 Nov; 60(11):3251-6. PubMed ID: 19877054
[TBL] [Abstract][Full Text] [Related]
4. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
[TBL] [Abstract][Full Text] [Related]
5. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
[TBL] [Abstract][Full Text] [Related]
6. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Di Benedetto P; Cipriani P; Giacomelli R; Gerli R
Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
Jousse-Joulin S; Devauchelle-Pensec V; Cornec D; Marhadour T; Bressollette L; Gestin S; Pers JO; Nowak E; Saraux A
Arthritis Rheumatol; 2015 Jun; 67(6):1623-8. PubMed ID: 25708147
[TBL] [Abstract][Full Text] [Related]
10. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
11. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Lisi S; Sisto M; D'Amore M; Lofrumento DD
Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
[TBL] [Abstract][Full Text] [Related]
12. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome.
Pijpe J; Kalk WW; van der Wal JE; Vissink A; Kluin PM; Roodenburg JL; Bootsma H; Kallenberg CG; Spijkervet FK
Rheumatology (Oxford); 2007 Feb; 46(2):335-41. PubMed ID: 16891656
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome.
Mossel E; Delli K; van Nimwegen JF; Stel AJ; Kroese FGM; Spijkervet FKL; Vissink A; Arends S; Bootsma H;
Ann Rheum Dis; 2017 Nov; 76(11):1883-1889. PubMed ID: 28754802
[TBL] [Abstract][Full Text] [Related]
15. Ig gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjögren's syndrome patients.
Hamza N; Hershberg U; Kallenberg CG; Vissink A; Spijkervet FK; Bootsma H; Kroese FG; Bos NA
J Immunol; 2015 Jan; 194(2):514-21. PubMed ID: 25488989
[TBL] [Abstract][Full Text] [Related]
16. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
Haacke EA; van der Vegt B; Vissink A; Spijkervet FKL; Bootsma H; Kroese FGM
Ann Rheum Dis; 2017 Oct; 76(10):1781-1784. PubMed ID: 28710097
[TBL] [Abstract][Full Text] [Related]
17. Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
Fisher BA; Everett CC; Rout J; O'Dwyer JL; Emery P; Pitzalis C; Ng WF; Carr A; Pease CT; Price EJ; Sutcliffe N; Makdissi J; Tappuni AR; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Richards A; Sharples LD; Bombardieri M; Bowman SJ
Ann Rheum Dis; 2018 Mar; 77(3):412-416. PubMed ID: 29275334
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous interstitial nephritis associated with Primary Sjögren's syndrome.
Bitik B; Gonul II; Haznedaroglu S; Goker B; Tufan A
Z Rheumatol; 2017 Jun; 76(5):458-460. PubMed ID: 28197771
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren's syndrome.
Deroo L; Genbrugge E; Dochy F; Creytens D; Achten H; De Boeck K; Bauters W; Roels D; Deprez J; Van den Bosch F; Elewaut D; Peene I
Rheumatology (Oxford); 2023 Aug; 62(8):2765-2772. PubMed ID: 36573316
[TBL] [Abstract][Full Text] [Related]
20. Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjögren's syndrome.
Bozinović MT; Katić V; Krasić D; Veselinović D; Jovanović P; Krstić M
Vojnosanit Pregl; 2009 Dec; 66(12):955-60. PubMed ID: 20095514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
